Global Sufentanil (API) Market Growth 2022-2028
- LP 4843360
- 93 Pages
- February 2022
- Pharmaceuticals
The United States Sufentanil (API) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Sufentanil (API) market, reaching US$ million by the year 2028. As for the Europe Sufentanil (API) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Sufentanil (API) players cover Kern Pharma, Cambrex, Hameln Rds, and Cristalia, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Sufentanil (API) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Purity 98%
Purity 99%
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Injection
Capsule
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Kern Pharma
Cambrex
Hameln Rds
Cristalia
Janssen Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sufentanil (API) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Sufentanil (API) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Sufentanil (API) by Country/Region, 2017, 2022 & 2028
2.2 Sufentanil (API) Segment by Type
2.2.1 Purity 98%
2.2.2 Purity 99%
2.3 Sufentanil (API) Sales by Type
2.3.1 Global Sufentanil (API) Sales Market Share by Type (2017-2022)
2.3.2 Global Sufentanil (API) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Sufentanil (API) Sale Price by Type (2017-2022)
2.4 Sufentanil (API) Segment by Application
2.4.1 Injection
2.4.2 Capsule
2.5 Sufentanil (API) Sales by Application
2.5.1 Global Sufentanil (API) Sale Market Share by Application (2017-2022)
2.5.2 Global Sufentanil (API) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Sufentanil (API) Sale Price by Application (2017-2022)
3 Global Sufentanil (API) by Company
3.1 Global Sufentanil (API) Breakdown Data by Company
3.1.1 Global Sufentanil (API) Annual Sales by Company (2020-2022)
3.1.2 Global Sufentanil (API) Sales Market Share by Company (2020-2022)
3.2 Global Sufentanil (API) Annual Revenue by Company (2020-2022)
3.2.1 Global Sufentanil (API) Revenue by Company (2020-2022)
3.2.2 Global Sufentanil (API) Revenue Market Share by Company (2020-2022)
3.3 Global Sufentanil (API) Sale Price by Company
3.4 Key Manufacturers Sufentanil (API) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sufentanil (API) Product Location Distribution
3.4.2 Players Sufentanil (API) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sufentanil (API) by Geographic Region
4.1 World Historic Sufentanil (API) Market Size by Geographic Region (2017-2022)
4.1.1 Global Sufentanil (API) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Sufentanil (API) Annual Revenue by Geographic Region
4.2 World Historic Sufentanil (API) Market Size by Country/Region (2017-2022)
4.2.1 Global Sufentanil (API) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Sufentanil (API) Annual Revenue by Country/Region
4.3 Americas Sufentanil (API) Sales Growth
4.4 APAC Sufentanil (API) Sales Growth
4.5 Europe Sufentanil (API) Sales Growth
4.6 Middle East & Africa Sufentanil (API) Sales Growth
5 Americas
5.1 Americas Sufentanil (API) Sales by Country
5.1.1 Americas Sufentanil (API) Sales by Country (2017-2022)
5.1.2 Americas Sufentanil (API) Revenue by Country (2017-2022)
5.2 Americas Sufentanil (API) Sales by Type
5.3 Americas Sufentanil (API) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sufentanil (API) Sales by Region
6.1.1 APAC Sufentanil (API) Sales by Region (2017-2022)
6.1.2 APAC Sufentanil (API) Revenue by Region (2017-2022)
6.2 APAC Sufentanil (API) Sales by Type
6.3 APAC Sufentanil (API) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sufentanil (API) by Country
7.1.1 Europe Sufentanil (API) Sales by Country (2017-2022)
7.1.2 Europe Sufentanil (API) Revenue by Country (2017-2022)
7.2 Europe Sufentanil (API) Sales by Type
7.3 Europe Sufentanil (API) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sufentanil (API) by Country
8.1.1 Middle East & Africa Sufentanil (API) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Sufentanil (API) Revenue by Country (2017-2022)
8.2 Middle East & Africa Sufentanil (API) Sales by Type
8.3 Middle East & Africa Sufentanil (API) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sufentanil (API)
10.3 Manufacturing Process Analysis of Sufentanil (API)
10.4 Industry Chain Structure of Sufentanil (API)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sufentanil (API) Distributors
11.3 Sufentanil (API) Customer
12 World Forecast Review for Sufentanil (API) by Geographic Region
12.1 Global Sufentanil (API) Market Size Forecast by Region
12.1.1 Global Sufentanil (API) Forecast by Region (2023-2028)
12.1.2 Global Sufentanil (API) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sufentanil (API) Forecast by Type
12.7 Global Sufentanil (API) Forecast by Application
13 Key Players Analysis
13.1 Kern Pharma
13.1.1 Kern Pharma Company Information
13.1.2 Kern Pharma Sufentanil (API) Product Offered
13.1.3 Kern Pharma Sufentanil (API) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Kern Pharma Main Business Overview
13.1.5 Kern Pharma Latest Developments
13.2 Cambrex
13.2.1 Cambrex Company Information
13.2.2 Cambrex Sufentanil (API) Product Offered
13.2.3 Cambrex Sufentanil (API) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Cambrex Main Business Overview
13.2.5 Cambrex Latest Developments
13.3 Hameln Rds
13.3.1 Hameln Rds Company Information
13.3.2 Hameln Rds Sufentanil (API) Product Offered
13.3.3 Hameln Rds Sufentanil (API) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Hameln Rds Main Business Overview
13.3.5 Hameln Rds Latest Developments
13.4 Cristalia
13.4.1 Cristalia Company Information
13.4.2 Cristalia Sufentanil (API) Product Offered
13.4.3 Cristalia Sufentanil (API) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Cristalia Main Business Overview
13.4.5 Cristalia Latest Developments
13.5 Janssen Pharmaceuticals
13.5.1 Janssen Pharmaceuticals Company Information
13.5.2 Janssen Pharmaceuticals Sufentanil (API) Product Offered
13.5.3 Janssen Pharmaceuticals Sufentanil (API) Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Janssen Pharmaceuticals Main Business Overview
13.5.5 Janssen Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Sufentanil (API) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Sufentanil (API) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Purity 98%
Table 4. Major Players of Purity 99%
Table 5. Global Sufentanil (API) Sales by Type (2017-2022) & (K Units)
Table 6. Global Sufentanil (API) Sales Market Share by Type (2017-2022)
Table 7. Global Sufentanil (API) Revenue by Type (2017-2022) & ($ million)
Table 8. Global Sufentanil (API) Revenue Market Share by Type (2017-2022)
Table 9. Global Sufentanil (API) Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Sufentanil (API) Sales by Application (2017-2022) & (K Units)
Table 11. Global Sufentanil (API) Sales Market Share by Application (2017-2022)
Table 12. Global Sufentanil (API) Revenue by Application (2017-2022)
Table 13. Global Sufentanil (API) Revenue Market Share by Application (2017-2022)
Table 14. Global Sufentanil (API) Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Sufentanil (API) Sales by Company (2020-2022) & (K Units)
Table 16. Global Sufentanil (API) Sales Market Share by Company (2020-2022)
Table 17. Global Sufentanil (API) Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Sufentanil (API) Revenue Market Share by Company (2020-2022)
Table 19. Global Sufentanil (API) Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Sufentanil (API) Producing Area Distribution and Sales Area
Table 21. Players Sufentanil (API) Products Offered
Table 22. Sufentanil (API) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Sufentanil (API) Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Sufentanil (API) Sales Market Share Geographic Region (2017-2022)
Table 27. Global Sufentanil (API) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Sufentanil (API) Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Sufentanil (API) Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Sufentanil (API) Sales Market Share by Country/Region (2017-2022)
Table 31. Global Sufentanil (API) Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Sufentanil (API) Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Sufentanil (API) Sales by Country (2017-2022) & (K Units)
Table 34. Americas Sufentanil (API) Sales Market Share by Country (2017-2022)
Table 35. Americas Sufentanil (API) Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Sufentanil (API) Revenue Market Share by Country (2017-2022)
Table 37. Americas Sufentanil (API) Sales by Type (2017-2022) & (K Units)
Table 38. Americas Sufentanil (API) Sales Market Share by Type (2017-2022)
Table 39. Americas Sufentanil (API) Sales by Application (2017-2022) & (K Units)
Table 40. Americas Sufentanil (API) Sales Market Share by Application (2017-2022)
Table 41. APAC Sufentanil (API) Sales by Region (2017-2022) & (K Units)
Table 42. APAC Sufentanil (API) Sales Market Share by Region (2017-2022)
Table 43. APAC Sufentanil (API) Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Sufentanil (API) Revenue Market Share by Region (2017-2022)
Table 45. APAC Sufentanil (API) Sales by Type (2017-2022) & (K Units)
Table 46. APAC Sufentanil (API) Sales Market Share by Type (2017-2022)
Table 47. APAC Sufentanil (API) Sales by Application (2017-2022) & (K Units)
Table 48. APAC Sufentanil (API) Sales Market Share by Application (2017-2022)
Table 49. Europe Sufentanil (API) Sales by Country (2017-2022) & (K Units)
Table 50. Europe Sufentanil (API) Sales Market Share by Country (2017-2022)
Table 51. Europe Sufentanil (API) Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Sufentanil (API) Revenue Market Share by Country (2017-2022)
Table 53. Europe Sufentanil (API) Sales by Type (2017-2022) & (K Units)
Table 54. Europe Sufentanil (API) Sales Market Share by Type (2017-2022)
Table 55. Europe Sufentanil (API) Sales by Application (2017-2022) & (K Units)
Table 56. Europe Sufentanil (API) Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Sufentanil (API) Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Sufentanil (API) Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Sufentanil (API) Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Sufentanil (API) Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Sufentanil (API) Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Sufentanil (API) Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Sufentanil (API) Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Sufentanil (API) Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Sufentanil (API)
Table 66. Key Market Challenges & Risks of Sufentanil (API)
Table 67. Key Industry Trends of Sufentanil (API)
Table 68. Sufentanil (API) Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Sufentanil (API) Distributors List
Table 71. Sufentanil (API) Customer List
Table 72. Global Sufentanil (API) Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Sufentanil (API) Sales Market Forecast by Region
Table 74. Global Sufentanil (API) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Sufentanil (API) Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Sufentanil (API) Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Sufentanil (API) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Sufentanil (API) Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Sufentanil (API) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Sufentanil (API) Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Sufentanil (API) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Sufentanil (API) Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Sufentanil (API) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Sufentanil (API) Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Sufentanil (API) Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Sufentanil (API) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Sufentanil (API) Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Sufentanil (API) Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Sufentanil (API) Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Sufentanil (API) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Sufentanil (API) Revenue Market Share Forecast by Application (2023-2028)
Table 92. Kern Pharma Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 93. Kern Pharma Sufentanil (API) Product Offered
Table 94. Kern Pharma Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Kern Pharma Main Business
Table 96. Kern Pharma Latest Developments
Table 97. Cambrex Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 98. Cambrex Sufentanil (API) Product Offered
Table 99. Cambrex Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Cambrex Main Business
Table 101. Cambrex Latest Developments
Table 102. Hameln Rds Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 103. Hameln Rds Sufentanil (API) Product Offered
Table 104. Hameln Rds Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Hameln Rds Main Business
Table 106. Hameln Rds Latest Developments
Table 107. Cristalia Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 108. Cristalia Sufentanil (API) Product Offered
Table 109. Cristalia Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Cristalia Main Business
Table 111. Cristalia Latest Developments
Table 112. Janssen Pharmaceuticals Basic Information, Sufentanil (API) Manufacturing Base, Sales Area and Its Competitors
Table 113. Janssen Pharmaceuticals Sufentanil (API) Product Offered
Table 114. Janssen Pharmaceuticals Sufentanil (API) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Janssen Pharmaceuticals Main Business
Table 116. Janssen Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Sufentanil (API)
Figure 2. Sufentanil (API) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sufentanil (API) Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Sufentanil (API) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Sufentanil (API) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Purity 98%
Figure 10. Product Picture of Purity 99%
Figure 11. Global Sufentanil (API) Sales Market Share by Type in 2021
Figure 12. Global Sufentanil (API) Revenue Market Share by Type (2017-2022)
Figure 13. Sufentanil (API) Consumed in Injection
Figure 14. Global Sufentanil (API) Market: Injection (2017-2022) & (K Units)
Figure 15. Sufentanil (API) Consumed in Capsule
Figure 16. Global Sufentanil (API) Market: Capsule (2017-2022) & (K Units)
Figure 17. Global Sufentanil (API) Sales Market Share by Application (2017-2022)
Figure 18. Global Sufentanil (API) Revenue Market Share by Application in 2021
Figure 19. Sufentanil (API) Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Sufentanil (API) Revenue Market Share by Company in 2021
Figure 21. Global Sufentanil (API) Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Sufentanil (API) Revenue Market Share by Geographic Region in 2021
Figure 23. Global Sufentanil (API) Sales Market Share by Region (2017-2022)
Figure 24. Global Sufentanil (API) Revenue Market Share by Country/Region in 2021
Figure 25. Americas Sufentanil (API) Sales 2017-2022 (K Units)
Figure 26. Americas Sufentanil (API) Revenue 2017-2022 ($ Millions)
Figure 27. APAC Sufentanil (API) Sales 2017-2022 (K Units)
Figure 28. APAC Sufentanil (API) Revenue 2017-2022 ($ Millions)
Figure 29. Europe Sufentanil (API) Sales 2017-2022 (K Units)
Figure 30. Europe Sufentanil (API) Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Sufentanil (API) Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Sufentanil (API) Revenue 2017-2022 ($ Millions)
Figure 33. Americas Sufentanil (API) Sales Market Share by Country in 2021
Figure 34. Americas Sufentanil (API) Revenue Market Share by Country in 2021
Figure 35. United States Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Sufentanil (API) Sales Market Share by Region in 2021
Figure 40. APAC Sufentanil (API) Revenue Market Share by Regions in 2021
Figure 41. China Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Sufentanil (API) Sales Market Share by Country in 2021
Figure 48. Europe Sufentanil (API) Revenue Market Share by Country in 2021
Figure 49. Germany Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Sufentanil (API) Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Sufentanil (API) Revenue Market Share by Country in 2021
Figure 56. Egypt Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Sufentanil (API) Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Sufentanil (API) in 2021
Figure 62. Manufacturing Process Analysis of Sufentanil (API)
Figure 63. Industry Chain Structure of Sufentanil (API)
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
